An estimated one billion people worldwide suffer from neglected tropical diseases (NTD), which occur mostly in tropical areas, and where people have limited access to clean water, quality health care, and proper sanitation.
While NTDs are preventable and treatable, access to quality-assured NTD medicines is a public health challenge in many countries due to the lack of objective information and data on their sources and supply.
In collaboration with USAID, which fights NTDs in more than 30 countries in Africa, Asia, and Latin America, PQM+ developed a publicly accessible web-based application: The Neglected Tropical Diseases Medicines Information Dashboard (NTD MID).
This dashboard is a centralized location of information on the source (country of origin, producer), dosage forms and strengths, source of approval, quality, reported shortage, and pricing of NTD medicines - both for finished pharmaceutical products (FPPs) and active pharmaceutical ingredients (APIs) . It focuses on seven preventive chemotherapy and transmission control (PCT) NTD medicines of interest: albendazole, azithromycin, diethylcarbamazine, ivermectin, mebendazole, praziquantel, and tetracycline eye ointment.
The NTD dashboard collates publicly available information for PCT NTD products that have been approved by stringent regulatory authorities, regulatory authorities with WHO maturity level 3 or 4, WHO Prequalification (PQ), and Expert Review Panel (ERP). It also provides links to relevant resources such as WHO PQ expressions of interest and the UNICEF supply catalogue for NTD medicines.
The information can be used by regulatory authorities, procurement agents, manufacturers, suppliers, donors, and other organizations working to increase availability of quality-assured NTD medicines.
The dashboard is free to use, just click on "Public Access" to begin your search. If you wish to contribute data, please register as a data provider.
